ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
Clinical trial NCT00034346 · COMPLETED
Trial details
- NCT number
- NCT00034346
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.